Neuromuscular function in different stages of sarcopenia

Area of Science:

• Gerontology
• Neuromuscular Physiology
• Sarcopenia Research

Background:

• Sarcopenia, the age-related loss of muscle mass and strength, significantly impacts older adults' functional capacity.
• The European Working Group on Sarcopenia in Older People (EWGSOP) provides a screening tool for sarcopenia, but its correlation with specific neuromuscular deficits requires further investigation.

Purpose of the Study:

• To evaluate laboratory-based neuromuscular function in older adults categorized into different sarcopenia stages (pre-sarcopenia, sarcopenia, severe sarcopenia) using the EWGSOP screening tool.
• To identify specific neuromuscular differences associated with sarcopenia severity in healthy, independent older adults.

Main Methods:

• Twenty-four healthy older adults (mean age 79.1±5.8 years) were assessed using the EWGSOP criteria (gait speed, handgrip strength, muscle mass).
• Neuromuscular function was evaluated through maximal voluntary contractions (MVCs), voluntary activation (interpolated twitch technique), isometric evoked contractile properties, and skeletal muscle mass assessment via ultrasound.
• Participants were categorized into pre-sarcopenia, sarcopenia, and severe sarcopenia groups.

Main Results:

• Gait speed was significantly slower in the severe sarcopenic group compared to the pre-sarcopenic group (p<0.01).
• Severe sarcopenic subjects exhibited 29% lower MVCs (p=0.02) and 19% slower rates of torque development (RTD) (p=0.02) compared to sarcopenic subjects.
• Peak twitch tension was 54% lower (p<0.01) in the severe group versus the pre-sarcopenic group, with significantly slower maximal twitch RTD in severe sarcopenic individuals.

Conclusions:

• The EWGSOP categorization scheme is relevant for identifying older adults with distinct neuromuscular properties.
• Neuromuscular deficits, particularly in maximal voluntary contractions and rate of torque development, are evident in severe sarcopenia.
• Further research is needed to elucidate specific neuromuscular changes across sarcopenia stages and their functional implications for targeted interventions.